Ignite Creation Date:
2024-05-06 @ 3:09 PM
Last Modification Date:
2024-10-26 @ 1:43 PM
Study NCT ID:
NCT04533945
Status:
COMPLETED
Last Update Posted:
2022-01-11
First Post:
2020-07-20
Brief Title:
Feasibility of Using the CGM During TOC From in Persons With T2D Using Insulin
Sponsor:
Northwell Health
Organization:
Northwell Health
Study Overview
Official Title:
The Feasibility of Using the FreeStyle Libre Flash Glucose Monitoring System During the Transition of Care TOC From Inpatient to Outpatient in Persons With Type 2 Diabetes T2D Using BasalBolus Insulin
Status:
COMPLETED
Status Verified Date:
2022-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Using the Libre during the TOC with persons with T2D will improve patient glucose monitoring and satisfaction which can potentially lead to an improvement in glycemic control and hospital utilization This study aims to assess this with inpatients using insulin
Detailed Description:
Integrating the use of the Libre during the TOC will improve patient glucose monitoring and satisfaction which can potentially lead to an improvement in glycemic control and hospital utilization Inpatients admitted to the medical-surgical units would be considered based on the inclusion and exclusion criteria If the patient qualifies they would be consented to participate in the trial In addition they would be given a script for refills Primary outcome is change in HbA1c and secondary outcomes at baseline and 90 days include satisfaction number of EDinpatient visits completion of follow-up appointment and duration of CGM use
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None